Hyperfine, Inc. Class A Common Stock (HYPR) is a publicly traded Healthcare sector company. As of May 21, 2026, HYPR trades at $1.49 with a market cap of $143.94M and a P/E ratio of -3.66. HYPR moved +5.67% today. Year to date, HYPR is +49.49%; over the trailing twelve months it is +137.83%. Its 52-week range spans $0.53 to $2.22. Analyst consensus is strong buy with an average price target of $2.17. Rallies surfaces HYPR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for HYPR combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $1.49 |
| Market Cap | $143.94M |
| P/E Ratio | -3.66 |
| EPS | $-0.40 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.22 |
| 52-Week Low | $0.53 |
| Volume | 50 |
| Avg Volume | 0 |
| Revenue (TTM) | $15.33M |
| Net Income | $-34.78M |
| Gross Margin | 51.20% |
3 analysts cover HYPR: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $2.17.